Abeona Therapeutics Inc
F:PCJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abeona Therapeutics Inc
F:PCJ
|
US |
|
P
|
Pitney Bowes Inc
DUS:PBW
|
US |
|
C
|
Computacenter PLC
F:COUD
|
UK |
|
Utah Medical Products Inc
F:UTM
|
US |
Intrinsic Value
Is PCJ undervalued or overvalued?
See the intrinsic value estimate for
Abeona Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Abeona Therapeutics Does
Abeona Therapeutics is a biotechnology company focused on gene and cell therapies for rare genetic diseases. It tries to fix the underlying DNA problem behind a disorder, rather than just treating symptoms. Its work has centered on diseases that affect the eyes, the immune system, and other inherited conditions with very limited treatment options.
- Headquarters
- United States of America US
- Employees
- 226
- IPO date
- Sep 19, 1980
Revenue & Expenses Breakdown
Abeona Therapeutics Inc
Earnings Waterfall
Abeona Therapeutics Inc
The intrinsic value for
Abeona Therapeutics Inc (PCJ) under the Base Case is hidden EUR.
Compared with the current market price of 4.021 EUR, the stock appears hidden.